nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—ABCG2—Dactinomycin—ocular cancer	0.248	0.598	CbGbCtD
Cladribine—ABCG2—Carboplatin—ocular cancer	0.167	0.402	CbGbCtD
Cladribine—Extravasation—Carboplatin—ocular cancer	0.00143	0.105	CcSEcCtD
Cladribine—Phlebitis—Carboplatin—ocular cancer	0.00105	0.077	CcSEcCtD
Cladribine—Myelosuppression—Dactinomycin—ocular cancer	0.000988	0.0724	CcSEcCtD
Cladribine—RRM2B—eye—ocular cancer	0.000791	0.133	CbGeAlD
Cladribine—Febrile neutropenia—Dactinomycin—ocular cancer	0.00077	0.0564	CcSEcCtD
Cladribine—POLE3—eye—ocular cancer	0.000748	0.125	CbGeAlD
Cladribine—PNP—lymphoid tissue—ocular cancer	0.0006	0.101	CbGeAlD
Cladribine—Extravasation—Dactinomycin—ocular cancer	0.000531	0.0389	CcSEcCtD
Cladribine—POLE3—lymphoid tissue—ocular cancer	0.000527	0.0884	CbGeAlD
Cladribine—NR5A1—lymphoid tissue—ocular cancer	0.00051	0.0856	CbGeAlD
Cladribine—POLA1—retina—ocular cancer	0.000487	0.0817	CbGeAlD
Cladribine—Infection—Carboplatin—ocular cancer	0.000442	0.0324	CcSEcCtD
Cladribine—Aplastic anaemia—Dactinomycin—ocular cancer	0.000435	0.0319	CcSEcCtD
Cladribine—Sepsis—Dactinomycin—ocular cancer	0.000402	0.0295	CcSEcCtD
Cladribine—POLE—lymphoid tissue—ocular cancer	0.000402	0.0674	CbGeAlD
Cladribine—Phlebitis—Dactinomycin—ocular cancer	0.00039	0.0286	CcSEcCtD
Cladribine—RRM1—eye—ocular cancer	0.00039	0.0655	CbGeAlD
Cladribine—RRM1—retina—ocular cancer	0.000387	0.0649	CbGeAlD
Cladribine—Pain—Carboplatin—ocular cancer	0.000381	0.0279	CcSEcCtD
Cladribine—Hepatic failure—Dactinomycin—ocular cancer	0.000374	0.0274	CcSEcCtD
Cladribine—Body temperature increased—Carboplatin—ocular cancer	0.000352	0.0258	CcSEcCtD
Cladribine—Lethargy—Dactinomycin—ocular cancer	0.000343	0.0251	CcSEcCtD
Cladribine—RRM2—lymphoid tissue—ocular cancer	0.000331	0.0555	CbGeAlD
Cladribine—Toxic epidermal necrolysis—Dactinomycin—ocular cancer	0.000303	0.0222	CcSEcCtD
Cladribine—DCK—retina—ocular cancer	0.0003	0.0504	CbGeAlD
Cladribine—Pancytopenia—Dactinomycin—ocular cancer	0.000276	0.0202	CcSEcCtD
Cladribine—RRM1—lymphoid tissue—ocular cancer	0.000275	0.0461	CbGeAlD
Cladribine—Neutropenia—Dactinomycin—ocular cancer	0.000272	0.0199	CcSEcCtD
Cladribine—Pneumonia—Dactinomycin—ocular cancer	0.000261	0.0191	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.000257	0.0188	CcSEcCtD
Cladribine—POLA1—G1/S Transition—RB1—ocular cancer	0.000256	0.000452	CbGpPWpGaD
Cladribine—POLE—S Phase—CDKN1B—ocular cancer	0.000254	0.000449	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—CDKN1A—ocular cancer	0.000253	0.000448	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—E2F3—ocular cancer	0.000251	0.000444	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.000251	0.000444	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000251	0.000444	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000249	0.000441	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.000248	0.000438	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000247	0.000437	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000245	0.000434	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000243	0.000429	CbGpPWpGaD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.000243	0.000429	CbGpPWpGaD
Cladribine—POLE—S Phase—CCND1—ocular cancer	0.000242	0.000428	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—EP300—ocular cancer	0.000241	0.000426	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000239	0.000422	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000238	0.000422	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—RBL2—ocular cancer	0.000238	0.00042	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN2B—ocular cancer	0.000236	0.000418	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000235	0.000416	CbGpPWpGaD
Cladribine—POLE—S Phase—CDKN1A—ocular cancer	0.000234	0.000414	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000234	0.000414	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.000233	0.000413	CbGpPWpGaD
Cladribine—POLA1—S Phase—RB1—ocular cancer	0.000232	0.000411	CbGpPWpGaD
Cladribine—Pharyngitis—Dactinomycin—ocular cancer	0.000231	0.0169	CcSEcCtD
Cladribine—RRM2—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00023	0.000407	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00023	0.000407	CbGpPWpGaD
Cladribine—POLE2—Mitotic M-M/G1 phases—RB1—ocular cancer	0.00023	0.000407	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000227	0.000402	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000226	0.0004	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000226	0.000399	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000225	0.000397	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—E2F3—ocular cancer	0.000224	0.000397	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—RBBP4—ocular cancer	0.000224	0.000397	CbGpPWpGaD
Cladribine—RRM2—G1/S Transition—MYC—ocular cancer	0.000223	0.000394	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GNA11—ocular cancer	0.000221	0.000392	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000221	0.000391	CbGpPWpGaD
Cladribine—POLA1—Synthesis of DNA—CDKN1B—ocular cancer	0.00022	0.00039	CbGpPWpGaD
Cladribine—Erythema multiforme—Dactinomycin—ocular cancer	0.00022	0.0161	CcSEcCtD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00022	0.000389	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000219	0.000387	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000217	0.000384	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—E2F1—ocular cancer	0.000217	0.000384	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000215	0.000381	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000215	0.000381	CbGpPWpGaD
Cladribine—POLE—G1/S Transition—MYC—ocular cancer	0.000214	0.000378	CbGpPWpGaD
Cladribine—DCK—lymphoid tissue—ocular cancer	0.000213	0.0358	CbGeAlD
Cladribine—POLA1—Cell Cycle—CDC25A—ocular cancer	0.000213	0.000377	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CCND3—ocular cancer	0.000211	0.000374	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MAML2—ocular cancer	0.00021	0.000372	CbGpPWpGaD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00021	0.000372	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—MYC—ocular cancer	0.00021	0.000371	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000209	0.00037	CbGpPWpGaD
Cladribine—POLE—Mitotic M-M/G1 phases—E2F1—ocular cancer	0.000209	0.00037	CbGpPWpGaD
Cladribine—Chills—Dactinomycin—ocular cancer	0.000209	0.0153	CcSEcCtD
Cladribine—POLA1—Cell Cycle—TFDP1—ocular cancer	0.000209	0.000369	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000208	0.000368	CbGpPWpGaD
Cladribine—POLA1—DNA Replication—CDKN1B—ocular cancer	0.000207	0.000366	CbGpPWpGaD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000206	0.000365	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDK6—ocular cancer	0.000206	0.000364	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GNAQ—ocular cancer	0.000206	0.000364	CbGpPWpGaD
Cladribine—Alopecia—Dactinomycin—ocular cancer	0.000206	0.0151	CcSEcCtD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000205	0.000362	CbGpPWpGaD
Cladribine—POLA1—Synthesis of DNA—CDKN1A—ocular cancer	0.000203	0.00036	CbGpPWpGaD
Cladribine—Erythema—Dactinomycin—ocular cancer	0.000203	0.0148	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—CDK4—ocular cancer	0.000202	0.000357	CbGpPWpGaD
Cladribine—POLA1—G1/S Transition—CDKN1B—ocular cancer	0.000199	0.000352	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000199	0.000351	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000198	0.00035	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000198	0.00035	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000198	0.00035	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000198	0.00035	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDK6—ocular cancer	0.000198	0.00035	CbGpPWpGaD
Cladribine—POLE—S Phase—MYC—ocular cancer	0.000194	0.000343	CbGpPWpGaD
Cladribine—PNP—Metabolism—GNA11—ocular cancer	0.000192	0.00034	CbGpPWpGaD
Cladribine—POLA1—DNA Replication—CDKN1A—ocular cancer	0.000191	0.000337	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00019	0.000336	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00019	0.000336	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CCND3—ocular cancer	0.000189	0.000334	CbGpPWpGaD
Cladribine—Ill-defined disorder—Dactinomycin—ocular cancer	0.000188	0.0138	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000188	0.000332	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000188	0.000332	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDK2—ocular cancer	0.000187	0.000331	CbGpPWpGaD
Cladribine—Anaemia—Dactinomycin—ocular cancer	0.000187	0.0137	CcSEcCtD
Cladribine—POLA1—G1/S Transition—CDKN1A—ocular cancer	0.000184	0.000325	CbGpPWpGaD
Cladribine—Malaise—Dactinomycin—ocular cancer	0.000183	0.0134	CcSEcCtD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000182	0.000323	CbGpPWpGaD
Cladribine—POLA1—S Phase—CDKN1B—ocular cancer	0.000181	0.00032	CbGpPWpGaD
Cladribine—POLE—Mitotic M-M/G1 phases—CDK2—ocular cancer	0.00018	0.000319	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—MYC—ocular cancer	0.00018	0.000319	CbGpPWpGaD
Cladribine—PNP—Metabolism—GNAQ—ocular cancer	0.000178	0.000316	CbGpPWpGaD
Cladribine—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	0.000178	0.000315	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000178	0.000314	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CCND2—ocular cancer	0.000177	0.000313	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—HDAC1—ocular cancer	0.000177	0.000313	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDK4—ocular cancer	0.000177	0.000313	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000173	0.000305	CbGpPWpGaD
Cladribine—Myalgia—Dactinomycin—ocular cancer	0.000172	0.0126	CcSEcCtD
Cladribine—POLA1—S Phase—CCND1—ocular cancer	0.000172	0.000305	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000172	0.000305	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—RB1—ocular cancer	0.000172	0.000304	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.00017	0.000302	CbGpPWpGaD
Cladribine—Discomfort—Dactinomycin—ocular cancer	0.00017	0.0125	CcSEcCtD
Cladribine—POLE—Cell Cycle—CCND2—ocular cancer	0.00017	0.000301	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—HDAC1—ocular cancer	0.00017	0.000301	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000168	0.000297	CbGpPWpGaD
Cladribine—POLA1—S Phase—CDKN1A—ocular cancer	0.000167	0.000295	CbGpPWpGaD
Cladribine—Oedema—Dactinomycin—ocular cancer	0.000165	0.0121	CcSEcCtD
Cladribine—Infection—Dactinomycin—ocular cancer	0.000164	0.012	CcSEcCtD
Cladribine—RRM2—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000163	0.000288	CbGpPWpGaD
Cladribine—Thrombocytopenia—Dactinomycin—ocular cancer	0.000162	0.0119	CcSEcCtD
Cladribine—POLA1—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00016	0.000283	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN2B—ocular cancer	0.000159	0.000281	CbGpPWpGaD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000158	0.000279	CbGpPWpGaD
Cladribine—Anorexia—Dactinomycin—ocular cancer	0.000158	0.0115	CcSEcCtD
Cladribine—POLA1—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000158	0.000279	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000156	0.000277	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000155	0.000274	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—RB1—ocular cancer	0.000154	0.000272	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—HDAC1—ocular cancer	0.000154	0.000272	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN2B—ocular cancer	0.000152	0.00027	CbGpPWpGaD
Cladribine—POLA1—G1/S Transition—MYC—ocular cancer	0.000152	0.000269	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000151	0.011	CcSEcCtD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00015	0.000265	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—E2F1—ocular cancer	0.000149	0.000264	CbGpPWpGaD
Cladribine—POLE—Mitotic M-M/G1 phases—RB1—ocular cancer	0.000148	0.000262	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—E2F1—ocular cancer	0.000146	0.000258	CbGpPWpGaD
Cladribine—Decreased appetite—Dactinomycin—ocular cancer	0.000144	0.0105	CcSEcCtD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000143	0.000253	CbGpPWpGaD
Cladribine—Fatigue—Dactinomycin—ocular cancer	0.000143	0.0104	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000142	0.000251	CbGpPWpGaD
Cladribine—Pain—Dactinomycin—ocular cancer	0.000141	0.0104	CcSEcCtD
Cladribine—POLA1—Cell Cycle—CDK6—ocular cancer	0.000141	0.000249	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000141	0.000249	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—E2F1—ocular cancer	0.00014	0.000247	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000139	0.000246	CbGpPWpGaD
Cladribine—POLA1—S Phase—MYC—ocular cancer	0.000138	0.000245	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—CDKN2B—ocular cancer	0.000138	0.000244	CbGpPWpGaD
Cladribine—Feeling abnormal—Dactinomycin—ocular cancer	0.000136	0.00998	CcSEcCtD
Cladribine—POLA1—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000135	0.00024	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000135	0.00024	CbGpPWpGaD
Cladribine—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000135	0.0099	CcSEcCtD
Cladribine—POLE—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000135	0.000239	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000134	0.000237	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000133	0.000235	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—MDM2—ocular cancer	0.000131	0.000232	CbGpPWpGaD
Cladribine—Abdominal pain—Dactinomycin—ocular cancer	0.000131	0.00957	CcSEcCtD
Cladribine—Body temperature increased—Dactinomycin—ocular cancer	0.000131	0.00957	CcSEcCtD
Cladribine—POLA1—Mitotic M-M/G1 phases—CDK2—ocular cancer	0.000129	0.000227	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000128	0.000227	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000128	0.000226	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000128	0.000226	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000127	0.000225	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDK2—ocular cancer	0.000126	0.000222	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000124	0.000219	CbGpPWpGaD
Cladribine—Hypersensitivity—Dactinomycin—ocular cancer	0.000122	0.00892	CcSEcCtD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000121	0.000215	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000121	0.000214	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—HDAC1—ocular cancer	0.000121	0.000214	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CCND2—ocular cancer	0.000121	0.000214	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDK2—ocular cancer	0.000121	0.000213	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—EP300—ocular cancer	0.00012	0.000212	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN1B—ocular cancer	0.00012	0.000212	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00012	0.000212	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDK4—ocular cancer	0.000119	0.00021	CbGpPWpGaD
Cladribine—Asthenia—Dactinomycin—ocular cancer	0.000119	0.00869	CcSEcCtD
Cladribine—POLE2—Cell Cycle, Mitotic—EP300—ocular cancer	0.000118	0.000208	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000117	0.000207	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—RB1—ocular cancer	0.000116	0.000204	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CCND1—ocular cancer	0.000114	0.000202	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDK4—ocular cancer	0.000114	0.000202	CbGpPWpGaD
Cladribine—Diarrhoea—Dactinomycin—ocular cancer	0.000113	0.00829	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000112	0.000197	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000111	0.000197	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—MYC—ocular cancer	0.000111	0.000196	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—RB1—ocular cancer	0.000111	0.000196	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN1A—ocular cancer	0.000111	0.000196	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GNA11—ocular cancer	0.00011	0.000195	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN2B—ocular cancer	0.000109	0.000192	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PSPH—ocular cancer	0.000108	0.000191	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PSPH—ocular cancer	0.000107	0.000189	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—RB1—ocular cancer	0.000106	0.000187	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—EP300—ocular cancer	0.000105	0.000186	CbGpPWpGaD
Cladribine—Vomiting—Dactinomycin—ocular cancer	0.000105	0.0077	CcSEcCtD
Cladribine—Rash—Dactinomycin—ocular cancer	0.000104	0.00764	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—TGFB1—ocular cancer	0.000104	0.000184	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—RB1—ocular cancer	0.000103	0.000183	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GNAQ—ocular cancer	0.000102	0.000181	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—MYC—ocular cancer	0.000102	0.000181	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—E2F1—ocular cancer	9.97e-05	0.000176	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PSPH—ocular cancer	9.95e-05	0.000176	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—RB1—ocular cancer	9.91e-05	0.000175	CbGpPWpGaD
Cladribine—Nausea—Dactinomycin—ocular cancer	9.82e-05	0.00719	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	9.72e-05	0.000172	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	9.7e-05	0.000172	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDK2—ocular cancer	9.61e-05	0.00017	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—MYC—ocular cancer	9.16e-05	0.000162	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDK4—ocular cancer	9.09e-05	0.000161	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GNA11—ocular cancer	9.08e-05	0.000161	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN1B—ocular cancer	8.99e-05	0.000159	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MDM2—ocular cancer	8.81e-05	0.000156	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN1B—ocular cancer	8.63e-05	0.000153	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	8.62e-05	0.000153	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDK2—ocular cancer	8.6e-05	0.000152	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CCND1—ocular cancer	8.58e-05	0.000152	CbGpPWpGaD
Cladribine—DCK—Metabolism—GNA11—ocular cancer	8.48e-05	0.00015	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MDM2—ocular cancer	8.45e-05	0.00015	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GNAQ—ocular cancer	8.44e-05	0.000149	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN1A—ocular cancer	8.3e-05	0.000147	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CCND1—ocular cancer	8.23e-05	0.000146	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—HRAS—ocular cancer	8.2e-05	0.000145	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDK4—ocular cancer	8.12e-05	0.000144	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN1B—ocular cancer	8.04e-05	0.000142	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	7.98e-05	0.000141	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN1A—ocular cancer	7.97e-05	0.000141	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—RB1—ocular cancer	7.9e-05	0.00014	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—EP300—ocular cancer	7.9e-05	0.00014	CbGpPWpGaD
Cladribine—DCK—Metabolism—GNAQ—ocular cancer	7.89e-05	0.00014	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN1B—ocular cancer	7.72e-05	0.000137	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CCND1—ocular cancer	7.67e-05	0.000136	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—EP300—ocular cancer	7.58e-05	0.000134	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—TP53—ocular cancer	7.53e-05	0.000133	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN1A—ocular cancer	7.42e-05	0.000131	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—EP300—ocular cancer	7.4e-05	0.000131	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CCND1—ocular cancer	7.36e-05	0.00013	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	7.26e-05	0.000128	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—AKT1—ocular cancer	7.24e-05	0.000128	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN1A—ocular cancer	7.12e-05	0.000126	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—RB1—ocular cancer	7.06e-05	0.000125	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—EP300—ocular cancer	7.06e-05	0.000125	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MYC—ocular cancer	6.88e-05	0.000122	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—EP300—ocular cancer	6.78e-05	0.00012	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—MDM2—ocular cancer	6.76e-05	0.00012	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	6.74e-05	0.000119	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MYC—ocular cancer	6.6e-05	0.000117	CbGpPWpGaD
Cladribine—PNP—Metabolism—EP300—ocular cancer	6.41e-05	0.000113	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MYC—ocular cancer	6.15e-05	0.000109	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN1B—ocular cancer	6.15e-05	0.000109	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MDM2—ocular cancer	6.02e-05	0.000107	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MYC—ocular cancer	5.91e-05	0.000104	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CCND1—ocular cancer	5.87e-05	0.000104	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN1A—ocular cancer	5.68e-05	0.0001	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—MDM2—ocular cancer	5.56e-05	9.84e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1B—ocular cancer	5.5e-05	9.73e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—EP300—ocular cancer	5.4e-05	9.55e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MYC—ocular cancer	5.34e-05	9.45e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CCND1—ocular cancer	5.25e-05	9.28e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—MDM2—ocular cancer	5.18e-05	9.17e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1A—ocular cancer	5.08e-05	8.98e-05	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—ocular cancer	5.05e-05	8.94e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—ocular cancer	4.85e-05	8.58e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—EP300—ocular cancer	4.83e-05	8.54e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MYC—ocular cancer	4.71e-05	8.33e-05	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKT1—ocular cancer	4.47e-05	7.91e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MYC—ocular cancer	4.21e-05	7.44e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	3.98e-05	7.04e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKT1—ocular cancer	3.88e-05	6.86e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—HRAS—ocular cancer	3.71e-05	6.57e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—AKT1—ocular cancer	3.7e-05	6.55e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—EP300—ocular cancer	3.68e-05	6.52e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—ocular cancer	3.46e-05	6.11e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GNA11—ocular cancer	3.4e-05	6.01e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GNA11—ocular cancer	3.36e-05	5.94e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GNAQ—ocular cancer	3.16e-05	5.58e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GNA11—ocular cancer	3.13e-05	5.54e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GNAQ—ocular cancer	3.12e-05	5.53e-05	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—HRAS—ocular cancer	3.05e-05	5.4e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—EP300—ocular cancer	3.03e-05	5.37e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GNAQ—ocular cancer	2.91e-05	5.15e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—HRAS—ocular cancer	2.84e-05	5.03e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—EP300—ocular cancer	2.83e-05	5.01e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKT1—ocular cancer	2.23e-05	3.94e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKT1—ocular cancer	1.83e-05	3.24e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKT1—ocular cancer	1.71e-05	3.03e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—EP300—ocular cancer	1.13e-05	2.01e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—EP300—ocular cancer	1.12e-05	1.99e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—EP300—ocular cancer	1.05e-05	1.85e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKT1—ocular cancer	6.85e-06	1.21e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKT1—ocular cancer	6.78e-06	1.2e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKT1—ocular cancer	6.32e-06	1.12e-05	CbGpPWpGaD
